Sort
48,018 grants matching “immunotherapy”
Novel immunological biomarkers ovarian cancer prognosis
$632,858Brahm H. Segal · Roswell Park Cancer Institute Corp · R01 · FY2018 · CA
Immunological consequences of LINE-1 expression in cancer
$632,855Katherine B Chiappinelli · George Washington University · R01 · FY2025 · CA
Development of a PET Tracer Selective for Cerebral Amyloid Angiopathy
$632,809Milos D Ikonomovic · University Of Pittsburgh At Pittsburgh · R01 · FY2016 · AG
NK/DC Cross-Talk and Antiviral Response
$632,784Luis J. Montaner · Wistar Institute · R01 · FY2008 · AI
Optimizing immunoradiotherapy for HNSCC
$632,764Joseph A Califano · University Of California, San Diego · R01 · FY2024 · CA
Project 3: Tools for Capturing Immune Cell/Cancer Cell Interactions in Cancer Immunotherapies and Combination Immunotherapies
$632,739James R. Heath · Institute For Systems Biology · U54 · FY2019 · CA
Gamma delta T cell based melanoma therapies
$632,718Xiaowei Xu · University Of Pennsylvania · R01 · FY2023 · CA
Microneedles for treatment of peanut allergy
$632,712Harvinder Singh Gill · Texas Tech University · R01 · FY2022 · AI
Genetic dissection of defensin signaling in urinary tract infections
$632,600Xintong Dong · University Of Texas Dallas · R01 · FY2024 · DK
Project 3: Spherical Nucleic Acids as Immunotherapeutic Agents for Prostate Cancer
$632,596Chad A. Mirkin · Northwestern University At Chicago · U54 · FY2015 · CA
Biomaterial Drones for Image-Guided Drug Delivery during radiotherapy
$632,501Wilfred Ngwa · Dana-Farber Cancer Inst · R01 · FY2020 · CA
Biomaterial Drones for Image-Guided Drug Delivery during radiotherapy
$632,501Wilfred Ngwa · Dana-Farber Cancer Inst · R01 · FY2019 · CA
Blending deep learning with probabilistic mechanistic models to predict and understand the evolution and function of adaptive immune receptors
$632,498Frederick Albert Matsen · Fred Hutchinson Cancer Research Center · R01 · FY2019 · AI
Radiation and dendritic cells to hepatomas to improve immunotherapy response
$632,389Sean S Park · Mayo Clinic Rochester · R01 · FY2022 · CA
Body composition and the obesity paradox in clear cell renal cell carcinoma
$632,341Anna Helena Furberg-Barnes · Sloan-Kettering Inst Can Research · R01 · FY2022 · CA
Targeting B7-H3 in ovarian cancer
$632,310Gianpietro Dotti · Univ Of North Carolina Chapel Hill · R01 · FY2021 · CA
Toward Translation of an Immunotherapeutic Nanomedicine for Neuroblastoma
$632,304John Tanner Wilson · Vanderbilt University · R01 · FY2023 · CA
Ultrahigh-throughput imaging of 3D tumor microenvironment at nanoscale
$632,300Yongxin Zhao · Carnegie-Mellon University · R01 · FY2025 · CA
Lymphangiogenesis in Pulmonary Lymphangioleiomyomatosis (LAM)
$632,220Vera P Krymskaya · University Of Pennsylvania · R01 · FY2019 · HL
Impact of ART on DC and Teg Responses in Oral Tissues
$632,205Melissa J Robbiani · Population Council · R01 · FY2008 · DE
Integrative Targeted Therapy for Melanoma
$632,195Jin-Ming Yang · University Of Kentucky · R01 · FY2024 · CA
Targeting GARP-TGFbeta for Immunotherapy of Non-Small Cell Lung Cancer
$632,185Zihai Li · Ohio State University · R01 · FY2025 · CA
The Yale Cancer Center Calabresi Immuno-Oncology Training Program (IOTP)
$632,154Harriet M Kluger · Yale University · K12 · FY2019 · CA
Therapy with fecal microbiota transplantation and immune checkpoint blockade for solid tumors
$632,135Hassane M Zarour · University Of Pittsburgh At Pittsburgh · U01 · FY2025 · CA
Reducing Cancer Transcriptional Heterogeneity through Regulation of Chromatin Structure
$632,115Vadim Backman · Northwestern University · R01 · FY2021 · CA